Bharatt Chowrira

Bharatt M.
Chowrira is the founder of Seaport Therapeutics, Inc. Current jobs include Director at Akili Interactive Labs, Inc., President & Chief Business & Legal Officer at PureTech Health LLC since 2017, Member of the Association of Corporate Counsel, and Member of The Colorado Bar Association.
Former jobs include President, Chief Executive Officer & Director at Addex Therapeutics Ltd. from 2011 to 2013, Chief Executive Officer & Director at PureTech Health Plc from 2017 to 2025, Executive Director-Licensing & External Research at Merck & Co., Inc. in 2008, Director at Cotinga Pharmaceuticals, Inc., Director at Traversa Therapeutics, Inc., Director at Karuna Therapeutics, Inc. from 2017 to 2019, Director at Vedanta Biosciences, Inc., Director at resTORbio, Inc., Director at Vor Biopharma, Inc., Independent Director at Akili, Inc. from 2021 to 2022, Chief Operating Officer & Senior Vice President at Nektar Therapeutics from 2009 to 2010, Chief Patent Counsel & VP-Legal Affairs at Sirna Therapeutics, Inc. in 2006, COO & Head-Business Development at Auspex Pharmaceuticals, Inc. from 2013 to 2015, and President at Synlogic, Inc. from 2015 to 2017.
Education includes a graduate degree from Illinois State University in 1989, an undergraduate degree from The University of Agricultural Sciences in 1986, a graduate degree from Sturm College of Law in 2001, and a doctorate from the University of Vermont College of Medicine in 1992.